Home › Funds › Spruce Street Capital LP › CATX
Spruce Street Capital LP position in CATX
PERSPECTIVE THERAPEUTICS INC · Health Care
Spruce Street Capital LP reported holding 3,693,931 shares of CATX (PERSPECTIVE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$10.2M, representing 1.62% of its reported portfolio and ranking #20 among its reported holdings. Spruce Street Capital LP has disclosed CATX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Spruce Street Capital LP's CATX position evolved
Spruce Street Capital LP first disclosed a stake in CATX in Q1 2026 at 2,627,107 shares (US$11.0M). The position peaked in Q2 2026 at 3,693,931 shares, worth US$12.6M. Across 3 filings, Spruce Street Capital LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 3,693,931 shares valued at US$10.2M. Notable position changes include a 41% increase in Q2 2026 (shares fell 19% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 2.63M | $10.96M | New |
| Q2 2026 | 3.69M | $12.60M | Add |
| Q3 2026 | 3.69M | $10.16M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CATX and 13F data
CATX (PERSPECTIVE THERAPEUTICS INC) is a Health Care company. 33 other funds we track also report a position in CATX — the largest reported positions include TCG Crossover Management, LLC (US$27.0M), Commodore Capital LP (US$21.6M), Avidity Partners Management LP (US$21.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CATX
- TCG Crossover Management, LLC 7.92M sh · $26.99M · Q2 2026
- Commodore Capital LP 6.34M sh · $21.61M · Q2 2026
- Avidity Partners Management LP 6.30M sh · $21.48M · Q2 2026
- Affinity Asset Advisors, LLC 3.99M sh · $10.97M · Q3 2026
- Nicholson Wealth Management Group, LLC 1.62M sh · $4.45M · Q3 2026
- Yu Fan 1.06M sh · $3.60M · Q2 2026
- Ally Bridge Group (NY) LLC 743.96K sh · $2.54M · Q2 2026
More on Spruce Street Capital LP
FAQ
How long has Spruce Street Capital LP held CATX?
Spruce Street Capital LP has disclosed CATX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Spruce Street Capital LP's current position in CATX?
As of Q3 2026, Spruce Street Capital LP holds 3.69M shares of CATX (PERSPECTIVE THERAPEUTICS INC), valued at $10.16M, representing 1.62% of its reported portfolio and ranking #20.
Has Spruce Street Capital LP been buying or selling CATX?
In the latest 13F filing (Q3 2026), Spruce Street Capital LP held unchanged its position in CATX. The position peaked in Q2 2026 at 3.69M shares.
Which other funds hold CATX?
Other major institutional holders of CATX include TCG Crossover Management, LLC, Commodore Capital LP, Avidity Partners Management LP, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.